Summary
Partner Kris Bieker presented a lecture, "Commercializing the Microbiome," at Princeton University's Molecular Biology Symposium in Princeton, NJ.
Speakers
- /en/people/b/bieker-kristina
Kristina Bieker
Partner
Related Content
- Big Molecule WatchJuly 25, 2024
FDA Issues Draft Guidance on Demonstrating Biosimilar Interchangeability
- Big Molecule WatchJuly 25, 2024
FDA Approves Samsung’s Eculizumab Biosimilar
- Life Sciences PerspectivesJuly 24, 2024
Common FDA Bioresearch Monitoring (BIMO) Violations: Updates from FY 2023 to Now
- AlertJuly 24, 2024
Common FDA Bioresearch Monitoring (BIMO) Violations: Updates from FY 2023 to Now
- Big Molecule WatchJuly 23, 2024
FTC Issues Interim Report on Ongoing Study of Pharmacy Benefit Managers
- Alert19 July 2024
Historic New Listing Rules Adopted for the UK
- AlertJuly 17, 2024
CTA Update: FinCEN Clarifies BOI Reporting Requirements for Dissolved Reporting Companies
- Big Molecule WatchJuly 12, 2024
Outlook Therapeutics Announces UK MHRA Marketing Authorization of LYTENAVA™ (bevacizumab gamma)
- Speaking EngagementsJuly 31, 2024 | 2:00 PM - 3:15 PM ET
ACS Webinar - Avoiding IP Own Goals in Drug Discovery: Best Practices for Obtaining (and Keeping) Your IP
- Press ReleaseJuly 24, 2024
Goodwin Advises Third Arc Bio on Oversubscribed $165 Million Series A Launch
- Press ReleaseJuly 18, 2024
Lantheus Acquires Global Rights to Life Molecular Imaging’s (“Life Molecular”) Novel Therapeutic and Diagnostic Pair Targeting GRPR for Prostate and Breast Cancers
- Awards and RankingsJuly 18, 2024
Goodwin Leads the H1 2024 League Table Rankings
- Awards and RankingsJuly 16, 2024
James Ding, Lynette Elam, and Peter Hanoian Named Law360 Rising Stars
- Press ReleaseJuly 11, 2024
Ascidian Therapeutics and Roche Collaborate on RNA Exon Editing for Neurological Diseases; Ascidian to Receive $42 Million Initial Payment, and Up to $1.8 Billion in Research, Clinical and Commercial Milestone Payments
- Press ReleaseJuly 9, 2024
Vigil Neuroscience Receives $40 Million Strategic Investment From Sanofi
- Press ReleaseJuly 8, 2024
Morphic Holding, Inc. to be Acquired by Eli Lilly and Company For $3.2 Billion